2.6.3. Component B: TMQQs
HIV viral suppression
Those randomized to an experimental condition that included the “on” level of this component received TMQQs over a 21-week period (a reasonable length of time during which to engage in care, re-initiate HIV medication, change adherence patterns, and achieve HIV viral suppression, if so desired). Each week a TM was sent to participants' phones, containing health and general HIV-related information including a hyperlink to more information, as appropriate, or a motivational message (see 